Vascepa
Product
Branded EPA medication (icosapent ethyl) manufactured by Amarin, proven to reduce macrovascular outcomes in the REDUCE-IT trial.
Mentioned in 3 videos
Videos Mentioning Vascepa
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
Branded EPA medication (icosapent ethyl) manufactured by Amarin, proven to reduce macrovascular outcomes in the REDUCE-IT trial.
#83 – Bill Harris, Ph.D.: Omega-3 fatty acids
Peter Attia MD
The trade name for icosapent ethyl, a very purified EPA ethyl ester, used in the REDUCE-IT study to reduce cardiovascular events.
Micronutrients for Health & Longevity | Dr. Rhonda Patrick
Andrew Huberman
A highly purified EPA prescription drug for hypertriglyceridemia, prescribed at 4 grams/day.